Medication info
NewsTojeong 20mg (Rosuvastatin Calcium)

NewsTojeong 20mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Daehan Newpharm Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201804841 · Approved 2018.11.30 · Insurance code 669907310

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Maximum daily dose: 20 milligrams. The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Daehan Newpharm Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is primarily used as an adjunct when dietary changes and exercise are insufficient to control hypercholesterolemia and mixed hyperlipidemia. It is particularly applicable for patients with familial hypercholesterolemia and is effective as an adjunct to dietary therapy in young pediatric patients who meet specific criteria. Moreover, this medication lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis. It is also helpful for patients with primary dysbetalipoproteinemia. Additionally, it is used in men over 50 years old and women over 60 years old with elevated high-sensitivity C-reactive protein levels and cardiovascular risk factors to reduce the risk of stroke, myocardial infarction, and endovascular procedures. Overall, this medication effectively improves cholesterol levels and cardiovascular disease risks.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Maximum daily dose: 20 milligrams. The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For instance, individuals allergic to the components of this medication, those with severe liver dysfunction, or patients with muscle disorders should avoid taking it. Furthermore, patients with severely impaired kidney function or those who are pregnant or breastfeeding should not use this medication. High-dose administration is prohibited for patients at high risk of muscle-related side effects. Patients with genetic lactose intolerance should also avoid taking this medication. Caution should be exercised when using this medication in patients with a history of liver disease or those who consume large amounts of alcohol, and it is advisable to perform liver function tests repeatedly before and after administration. Additionally, for conditions like hypothyroidism or nephrotic syndrome, it is safe to use this medication only after treating the underlying disease. Muscle-related side effects like muscle pain or myopathy may occur infrequently, so if any abnormal muscle symptoms arise, one should immediately inform the doctor and undergo testing. Since this medication can affect the liver and muscles, symptoms such as fatigue, muscle pain, and muscle weakness should be closely monitored during treatment. Especially after vigorous exercise, it is advisable to avoid testing for creatine kinase (CK), a muscle damage marker. If CK levels are too high before treatment, it is safest not to take this medication. This medication rarely causes serious skin reactions, liver damage, or kidney issues, so if symptoms such as rash or jaundice appear, one should immediately stop taking it and visit a hospital. Additionally, cognitive disorders such as memory decline or confusion have been reported in some patients; however, most symptoms improve after the discontinuation of the medication. This medication may interact with other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Especially when taken with certain antiviral agents, immunosuppressants, antibiotics, or fibrate-class drugs, the risk of muscle damage may increase. Dose adjustments or monitoring may be necessary when taken with this medication. Pregnant women or those planning to become pregnant should not take this medication and should use appropriate contraception. While breastfeeding, this medication can transfer to breast milk and affect the baby, so it should be avoided. In the case of overdose, there is no specific antidote, so treatment should be symptomatic, while closely monitoring liver function and muscle damage markers. This medication is known not to significantly affect the ability to operate vehicles or machinery; however, caution is advised due to possible dizziness symptoms. Lastly, this medication may show higher blood concentrations in Asians, so care should be taken when determining the dosage, and in the case of children or adolescents, it should be used while monitoring growth and development.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase increase, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, psoriasiform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, ALT increase, chest pain, muscle cramps, gout, erectile dysfunction, AST increase, numbness, paresthesia, chest discomfort, loss of appetite, abdominal bloating, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is advisable to keep it at a temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.